Vyvanse is a central nervous system (CNS) stimulant. More specifically, it belongs to the amphetamine class of medications and is classified as a Schedule II controlled substance under federal law, meaning it has legitimate medical uses but also carries a recognized potential for misuse and dependence. Its active ingredient, lisdexamfetamine dimesylate, is FDA-approved to treat ADHD in people ages 6 and older and moderate to severe binge eating disorder in adults.
How Vyvanse Differs From Other Stimulants
What makes Vyvanse unusual among stimulants is that it’s a prodrug. The medication itself is therapeutically inactive when you swallow it. Lisdexamfetamine is d-amphetamine (the active stimulant) chemically bonded to l-lysine, a naturally occurring amino acid. Your body has to break that bond during digestion before the d-amphetamine is released and becomes active. This built-in conversion step is the key distinction between Vyvanse and medications like Adderall, which contain amphetamine salts that are already active the moment they’re absorbed.
This prodrug design has two practical effects. First, the active ingredient is released gradually rather than all at once, which produces a smoother onset and a longer window of effect. Second, because the drug requires enzymatic conversion in the body, taking more of it at once doesn’t dramatically accelerate how quickly it kicks in, which is part of why it was designed this way.
Why It’s Schedule II
The DEA placed lisdexamfetamine into Schedule II of the Controlled Substances Act in 2007, the same schedule that includes other amphetamines, methylphenidate (the active ingredient in Ritalin and Concerta), and certain opioid painkillers. Schedule II is the most restrictive category for drugs that still have accepted medical use. In practical terms, this means Vyvanse prescriptions typically can’t be called in by phone, often can’t be refilled without a new prescription, and are subject to quantity limits that vary by state.
How Long It Works
Vyvanse is taken once daily in the morning. In clinical studies, it began improving attention within about 2 hours in adults and as early as 1.5 hours in children ages 6 to 12. The effects lasted up to 14 hours in adults and up to 13 hours in children. Peak blood levels of the released d-amphetamine occur roughly 3.5 to 4.5 hours after a dose. That long duration is one of the main reasons it’s prescribed: a single morning dose covers most of the waking day without needing a midday booster.
What Vyvanse Is Approved to Treat
Vyvanse has two FDA-approved uses. The first and most common is ADHD, approved for patients ages 6 and up, including adults. The second is moderate to severe binge eating disorder in adults. It is not approved for binge eating disorder in anyone under 18, and it is not approved for weight loss, though reduced appetite is a common side effect of stimulant medications in general.
How It Works in the Brain
Once the body converts lisdexamfetamine into d-amphetamine, it increases the activity of two chemical messengers in the brain: dopamine and norepinephrine. These chemicals play central roles in attention, motivation, and impulse control. In people with ADHD, the stimulant effect helps regulate the parts of the brain responsible for staying focused, organizing tasks, and filtering out distractions. The FDA label categorizes amphetamines like Vyvanse as “non-catecholamine sympathomimetic amines with CNS stimulant activity,” which in plain terms means they stimulate the nervous system in a way that mimics the body’s own alertness signals.
It may seem counterintuitive that a stimulant calms the symptoms of ADHD, but the prevailing understanding is that ADHD involves underactivity in the brain’s executive function networks. The stimulant doesn’t sedate you. Instead, it brings those underperforming circuits closer to typical activity levels, which makes it easier to regulate behavior and sustain attention.
Vyvanse vs. Adderall
Both medications ultimately deliver amphetamine to the brain, but they differ in composition and release profile. Adderall contains a mixture of four amphetamine salts, including both d-amphetamine and l-amphetamine. Vyvanse delivers only d-amphetamine, and only after the body cleaves it from its amino acid carrier. The result is that Vyvanse tends to have a more gradual onset and a longer, steadier duration compared to immediate-release Adderall, though Adderall XR (the extended-release version) narrows that gap somewhat.
The choice between them usually comes down to how a person responds individually, how long they need coverage during the day, and insurance or cost considerations. Since Vyvanse lost its patent exclusivity, generic lisdexamfetamine has become available, which has made it more affordable than it was for years.